| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 10, 1456-1463, Copyright © 1996 by The Federation of American Societies for Experimental Biology
REVIEWS |
K Makita, JR Falck and JH Capdevila
Department of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232, USA.
As a participant of the endogenous arachidonic acid metabolic cascade, microsomal cytochrome P450 metabolizes the fatty acid to biologically active hydroxyeicosatetraenoic and epoxyeicosatrienoic acids. Studies from several laboratories have documented the powerful vasoactive properties of these P450-derived eicosanoids. Associated changes in cell membrane ion permeability and fluxes may provide the molecular basis underlining their vasoactivity. Furthermore, a role for the P450 arachidonic acid monooxygenase in renal physiology and pathophysiology has been suggested by: 1) an association between the activities of the arachidonic acid omega/omega-1 oxygenase and the development of hypertension in spontaneously hypertensive rats, and 2) a relationship between acquired or inherited abnormalities in the renal epoxygenase activities and/or regulation and salt-sensitive hypertension in Dahl rats. These studies provide significant evidence to indicate that microsomal P450, in addition to its recognized traditional toxicological and pharmacological roles, may also play an important physiological role in the control of tissue and body homeostasis.
This article has been cited by other articles:
|
|
 |
|
  E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, J.-K. Chen, J. R. Falck, S. Anjaiah, J. H. Capdevila, and R. C. Harris Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate Metabolite Mol. Cell. Biol., April 15, 2007; 27(8): 3023 - 3034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Harder and R. J. Roman Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ. Res., April 14, 2006; 98(7): 866 - 867. [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff 5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR Hypertension, October 1, 2003; 42(4): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyazono, D. Zhu, R. Nemenoff, E. R. Jacobs, and E. P. Carter Increased Epoxyeicosatrienoic Acid Formation in the Rat Kidney during Liver Cirrhosis J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1766 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. Guengerich Cytochromes P450, Drugs, and Diseases Mol. Interv., June 1, 2003; 3(4): 194 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kaergel, D. N. Muller, H. Honeck, J. Theuer, E. Shagdarsuren, A. Mullally, F. C. Luft, and W.-H. Schunck P450-Dependent Arachidonic Acid Metabolism and Angiotensin II-Induced Renal Damage Hypertension, September 1, 2002; 40(3): 273 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-K. Chen, J. Capdevila, and R. C. Harris Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells PNAS, April 30, 2002; 99(9): 6029 - 6034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Imig, X. Zhao, J. H. Capdevila, C. Morisseau, and B. D. Hammock Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension Hypertension, February 1, 2002; 39(2): 690 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Chen, J. Capdevila, and R. C. Harris Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis Mol. Cell. Biol., September 15, 2001; 21(18): 6322 - 6331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Muthalif, F. Ljuca, J. B. Roaten, N. Pentapaty, M. R. Uddin, and K. U. Malik Ca2+/Calmodulin-Dependent Protein Kinase II and Cytosolic Phospholipase A2 Contribute to Mitogenic Signaling in Myeloblastic Leukemia U-937 Cells J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 272 - 278. [Abstract] [Full Text]
|
|
|
|
|
|
S. I. Pomposiello, M. A. Carroll, J. R. Falck, and J. C. McGiff Epoxyeicosatrienoic Acid-Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR Hypertension, March 1, 2001; 37(3): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Jacobs and D. C. Zeldin The lung HETEs (and EETs) up Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yu, F. Xu, L. M. Huse, C. Morisseau, A. J. Draper, J. W. Newman, C. Parker, L. Graham, M. M. Engler, B. D. Hammock, et al. Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids Circ. Res., November 24, 2000; 87(11): 992 - 998. [Abstract] [Full Text]
|
|
|
|
|
|
H. Honeck, V. Gross, B. Erdmann, E. Kargel, R. Neunaber, A. F. Milia, W. Schneider, F. C. Luft, and W.-H. Schunck Cytochrome P450-Dependent Renal Arachidonic Acid Metabolism in Desoxycorticosterone Acetate-Salt Hypertensive Mice Hypertension, October 1, 2000; 36(4): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Thompson, J. H. Capdevila, and H. W. Strobel Recombinant Cytochrome P450 2D18 Metabolism of Dopamine and Arachidonic Acid J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1120 - 1130. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Kozak, M. J. Kluger, A. Kozak, M. Wachulec, and K. Dokladny Role of cytochrome P-450 in endogenous antipyresis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R455 - R460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, L. M. Huse, P. Adler, L. Graham, J. Ma, D. C. Zeldin, and D. L. Kroetz Increased CYP2J Expression and Epoxyeicosatrienoic Acid Formation in Spontaneously Hypertensive Rat Kidney Mol. Pharmacol., May 1, 2000; 57(5): 1011 - 1020. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-K. Chen, J. Capdevila, and R. C. Harris Overexpression of C-terminal Src Kinase Blocks 14,15-Epoxyeicosatrienoic Acid-induced Tyrosine Phosphorylation and Mitogenesis J. Biol. Chem., April 28, 2000; 275(18): 13789 - 13792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lasker, W. B. Chen, I. Wolf, B. P. Bloswick, P. D. Wilson, and P. K. Powell Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney. ROLE OF CYP4F2 AND CYP4A11 J. Biol. Chem., February 11, 2000; 275(6): 4118 - 4126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. KOZAK, M. J. KLUGER, J. TESFAIGZI, A. KOZAK, K. P. MAYFIELD, M. WACHULEC, and K. DOKLADNY Molecular Mechanisms of Fever and Endogenous Antipyresis Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 121 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alonso-Galicia, J. R. Falck, K. M. Reddy, and R. J. Roman 20-HETE agonists and antagonists in the renal circulation Am J Physiol Renal Physiol, November 1, 1999; 277(5): F790 - F796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. M. Kerkhof, E. N. T. P. Bakker, and P. Sipkema Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1546 - H1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. GROSS, W. SCHNEIDER, W.-H. SCHUNCK, E. MERVAALA, and F. C. LUFT Chronic Effects of Lovastatin and Bezafibrate on Cortical and Medullary Hemodynamics in Deoxycorticosterone Acetate-Salt Hypertensive Mice J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1430 - 1439. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. S. Cummings, R. C. Zangar, R. F. Novak, and L. H. Lash Cellular Distribution of Cytochromes P-450 in the Rat Kidney Drug Metab. Dispos., April 1, 1999; 27(4): 542 - 548. [Abstract] [Full Text]
|
|
|
|
|
|
J.-K. Chen, D.-W. Wang, J. R. Falck, J. Capdevila, and a. R. C. Harris Transfection of an Active Cytochrome P450 Arachidonic Acid Epoxygenase Indicates That 14,15-Epoxyeicosatrienoic Acid Functions as an Intracellular Second Messenger in Response to Epidermal Growth Factor J. Biol. Chem., February 19, 1999; 274(8): 4764 - 4769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Chen, J. R. Falck, K. M. Reddy, J. Capdevila, and R. C. Harris Epoxyeicosatrienoic Acids and Their Sulfonimide Derivatives Stimulate Tyrosine Phosphorylation and Induce Mitogenesis in Renal Epithelial Cells J. Biol. Chem., October 30, 1998; 273(44): 29254 - 29261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Muthalif, I. F. Benter, N. Karzoun, S. Fatima, J. Harper, M. R. Uddin, and K. U. Malik 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells PNAS, October 13, 1998; 95(21): 12701 - 12706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Su, K. M. Kaushal, and D. L. Kroetz Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R426 - R438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Stephenson, R. S. Sprague, and A. J. Lonigro 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H100 - H109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Lohr, G. R. Willsky, and M. A. Acara Renal Drug Metabolism Pharmacol. Rev., March 1, 1998; 50(1): 107 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Husted, J. P. Rapp, and J. B. Stokes Candidate Genes in the Regulation of Na+ Transport by Inner Medullary Collecting Duct Cells From Dahl Rats Hypertension, February 1, 1998; 31(2): 608 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Uddin, M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik Cytochrome P-450 Metabolites Mediate Norepinephrine-Induced Mitogenic Signaling Hypertension, January 1, 1998; 31(1): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kitazume, N. Takaya, N. Nakayama, and H. Shoun Fusarium oxysporum Fatty-acid Subterminal Hydroxylase (CYP505) Is a Membrane-bound Eukaryotic Counterpart of Bacillus megaterium Cytochrome P450BM3 J. Biol. Chem., December 8, 2000; 275(50): 39734 - 39740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Zeldin Epoxygenase Pathways of Arachidonic Acid Metabolism J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
